Volume 8: Issue 5-6, May 2017
pp550-607
 |
About the CoverThe cover for the issue of Genes & Cancer features Figure 1A (“Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer”) from Jayaraman et al. |
Reviews
Telomere length regulation through epidermal growth factor receptor signaling in cancer
https://doi.org/10.18632/genesandcancer.140
Titto Augustine, Radhashree Maitra, and Sanjay Goel
p 550-558
Research Papers
Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation
https://doi.org/10.18632/genesandcancer.145
Takayasu Kurata, Aya Nakaya, Takashi Yokoi, Maiko Niki, Kayoko Kibata, Yuki Takeyasu, Yoshitaro Torii, Yuichi Katashiba, Makoto Ogata, Takayuki Miyara, and Shosaku Nomura
p 559-565
Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer
https://doi.org/10.18632/genesandcancer.144
Muralidharan Jayaraman, Rangasudhagar Radhakrishnan, Cara A. Mathews, Mingda Yan, Sanam Husain, Katherine M. Moxley, Yong Sang Song, and Danny N. Dhanasekaran
p 566-576
The chemokine scavenging receptor D6/ACKR2 is a target of miR-146a in thyroid cancer
https://doi.org/10.18632/genesandcancer.141
Francesco Pacifico, Alessio Lepore, Stefano Mellone, Luca Sanguigno, Giorgia Federico, Adelaide Greco, Arturo Brunetti, and Antonio Leonardi
p 577-588
EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
https://doi.org/10.18632/genesandcancer.142
Christine Mehner, Ann L. Oberg, Krista M. Goergen, Kimberly R. Kalli, Matthew J. Maurer, Aziza Nassar, Ellen L. Goode, Gary L. Keeney, Aminah Jatoi, Derek C. Radisky, and Evette S. Radisky
p 589-599
Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis
https://doi.org/10.18632/genesandcancer.143
Bin Liang, Jianying Zhao, and Xuan Wang
p 600-607